300 million child-friendly antimalarial treatments supplied without profit by Novartis
Novartis announced today that it has reached a delivery milestone of 300 million paediatric antimalarial…
Novartis announced today that it has reached a delivery milestone of 300 million paediatric antimalarial…
Using malaria rapid diagnostic tests (RDTs) in registered drug shops in a highly endemic region…